Assessing Acceptability, Cost, and Efficacy of STELLA-Support Via Technology
STELLA
2 other identifiers
interventional
28
1 country
1
Brief Summary
STELLA (Support via Technology Living and Learning with Advancing Alzheimer's disease and related dementias) is a multicomponent video-conference based intervention that aims to help family members caring for persons of dementia as well the person with dementia. The goal of this intervention is to reduce upsetting behaviors and care partner burden. Caring for a family member with Alzheimer's disease or related dementia (ADRD) can come with many burdens that affect not only the care partners' physical and psychological health but also barriers to access. Due to factors such as distance and cost, Internet-based interventions like STELLA are a great alternative to in-person interventions because it can still address the specific needs of families living with dementia. The hypothesis of this study is that care partners will show significant improvements in burden and depression following the intervention. STELLA is also designed to facilitate effective management of behavioral and psychological symptoms of dementia (BPSD). To accomplish this, up to 40 care partners and their 40 care recipients with Alzheimer's disease and related dementias will participate in an 8-week intervention with the support of a Guide (e.g. nurse or social worker). However, the primary focus of this study is on care partners. With the support of a Guide, care partners will identify strategies to address upsetting behaviors in the moderate to late stages of dementia. More specifically, a Guide will help care partners identify and modify distressing behavioral symptoms of dementia. Based on quantitative and qualitative approaches, the effect of the intervention on care partner affective symptoms, including depression and burden, as well as quality of life for both the care partner and the person with dementia will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2020
CompletedFirst Posted
Study publicly available on registry
April 6, 2020
CompletedStudy Start
First participant enrolled
March 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2023
CompletedResults Posted
Study results publicly available
January 23, 2024
CompletedJanuary 23, 2024
December 1, 2023
2.2 years
March 11, 2020
September 8, 2023
December 27, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Revised Memory and Behavior Problems Checklist
Care recipient frequency of behaviors and caregiver reactions to behavioral symptoms. The scale measures how often a behavior occurs (Frequency, "F") and how much the caregiver reacts to it (Reactivity, "R"). Range for both scales is 0-96, lower scores are better. Subscales are not combined.
The RMBPC is assessed 1 week prior to the 8-week intervention (pre), then 1 week after the intervention (post)
Center for Epidemiological Studies Depression Scale
Caregiver depression symptoms, Range 0-30, lower scores indicate less depression (better). Depression is only measured for the caregivers, not the care recipients with dementia (only 1 group)
1 week prior to the 8-week intervention (pre), then 1 week after the intervention (post)
Secondary Outcomes (5)
Desire to Institutionalize (DTI) Scale
Measured at study entry only
Marwit Meuser Caregiver Grief Index
1 week prior to the 8-week intervention (pre), then 1 week after the intervention (post)
Feasibility and Participant Acceptability
Measured only once by caregivers 1 week after 8-week intervention
Quality of Life in Alzheimer's Disease (QOL-AD) Scale
1 week prior to the 8-week intervention (pre), then 1 week after the intervention (post)
Sleep Duration
Measures sleep from enrollment to study end. Mean sleep hours one week prior to intervention (pre) and one week after intervention (post). Measured in hours (units on a scale)
Study Arms (1)
Intervention
OTHERCare Partners and Persons with Dementia. Up to 40 Care Partners and their 40 care-recipients with ADRD will participate in this study. The primary focus of this study is on Care Partners, however, we will gather subjective and objective data on participants with Alzheimer's Disease and Related Dementias (ADRD) to assess the effect of the intervention on Care Partner affective responses to caregiving and quality of life for both. STELLA participants will be recruited from the existing cohort of patients, and their Care Partners, who are enrolled in the Oregon Roybal Center for CAre Support Translational Research Advantaged by Integrating Technology) ORCASTRAIT Life Laboratory (OSLL).
Interventions
STELLA consists of 8 sessions: 4 sessions one-to-one, with the Care Partner and a Guide, and then 4 sessions with one Guide with up to four Care Partners (total small group will include as few as two and as many as 4 Care Partners) Each weekly session takes about 1 hour. The first four sessions allow for development of the Care Partner-Guide working relationship. In these sessions, the Care Partners identify behaviors (both the person with dementia's and the Care Partner's) which are upsetting to the family. Care Partners will be taught to use an Activator, Behavior, Consequence (ABC) approach to identify activators of behaviors, the behaviors, and consequences of the behaviors. After they identify the ABCs, they will develop a plan to address the behavior and then test it. After the four one-to-one sessions, Care Partners will meet in small groups with a Guide. Effective communication strategies, engagement in pleasant events, and coping will be addressed.
Eligibility Criteria
You may qualify if:
- Diagnosis of Alzheimer's Disease and Related Dementias (ADRD), moderate to late stages
- Exhibits 2 or more behaviors listed on Revised Memory and Behavioral Problems (RMBP) that are bothersome to the Care Partner and occur 3 or more times/week at study enrollment
- Family member of Care Partner (this can be a relative, spouse or close kin that is considered family)
You may not qualify if:
- Dementia not related to ADRD
- Unable to leave Care Partner during Care Partner training
- Early stage dementia, as defined by a Montreal Cognitive Assessment (MoCA) of about 15/30 or higher.
- Adult caring for family member with ADRD
- Lives with care recipient OR spends at least 4 hours/week with care recipient
- Age of 18 years or older
- Speak English
- Own a computer/device with a reliable internet connection and compatible operating system
- Unable to find activity for care recipient during training which would allow Care Partner to work privately, one-on-one during training
- Completed similar telehealth intervention within the last year
- Hearing and vision problems severe enough to prevent participation
- Unwilling or unable to adequately follow study instructions and participate in study procedures
- Participate in Oregon Roybal Center for CAre Support Translational Research Advantaged by Integrating Technology (ORCASTRAIT) (IRB#20236) Participant in the ORCASTRAIT study (IRB # 20236)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oregon Health and Science University, Layton Aging and Alzheimer's Disease Center
Portland, Oregon, 97239, United States
Related Publications (1)
Dawson WD, Mattek N, Gothard S, Kaye J, Lindauer A. Ascertaining Out-of-Pocket Costs of Dementia Care: Feasibility Study of a Web-Based Weekly Survey. JMIR Form Res. 2024 Sep 25;8:e56878. doi: 10.2196/56878.
PMID: 39321453DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Allison Lindauer
- Organization
- Oregon Health & Science University
Study Officials
- PRINCIPAL INVESTIGATOR
Walter Dawson, PhD
Oregon Health and Science University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 11, 2020
First Posted
April 6, 2020
Study Start
March 24, 2021
Primary Completion
June 1, 2023
Study Completion
June 15, 2023
Last Updated
January 23, 2024
Results First Posted
January 23, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will be available 1/2021, available indefinitely
- Access Criteria
- Requests need to made to the PI at the Oregon Alzheimer's Disease Research Center (OARDC). A short data request form will need to be submitted to the OADRC
De-identified IPD will be available upon request to our Alzheimer's Disease Research Center.